share_log

Enliven Therapeutics | 8-K: Enliven Therapeutics Highlights Business Achievements and Reports First Quarter 2023 Financial Results

SEC ·  May 11, 2023 16:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more